Skip to search formSkip to main contentSkip to account menu

NVP BEZ235

Known as: NVP-BEZ235, NVPBEZ235 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Purpose NVP-BEZ235 is a recently developed dual inhibitor of PI3K and mTOR and shows good inhibitory effects on several types of… 
2015
2015
NHL subtypes are classified based on clinical and histologic characteristics, as well as lymphocyte developmental stage. NHL sub… 
2014
2014
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most common malignant tumors still associated with poor… 
2013
2013
Mantle cell lymphoma (MCL) is an aggressive form of Non‐Hodgkin‐lymphoma (NHL) with an ongoing need for novel treatments. Apart… 
2012
2012
The mammalian target of rapamycin (mTOR) is regulated by oncogenic growth factor signals and plays a pivotal role in controlling… 
2012
2012
Objectives: Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for standard… 
Highly Cited
2009
Highly Cited
2009
Phosphatidylinositol 3-kinase (PI3K) has been implicated in a variety of diseases including cancer. A number of PI3K inhibitors…